ADALIMUMAB IS MORE EFFECTIVE THAN ETANERCEPT AT PREVENTING TNF-ENHANCED OSTEOCLAST DEVELOPMENT THROUGH DOWNREGULATION OF PRO-OSTEOCLASTOGENIC FACTORS ICAM-1 AND IGFBP2 AND UPREGULATION OF ANTI-OSTEOCLASTOGENIC FACTOR FABP4
- Resource Type
- Journal
- Source
ANNALS OF THE RHEUMATIC DISEASES ; JUN 2020, 79 p777-p777, 1p. Supplement: 1- Subject
- Language
- English
- ISSN
- 14682060